Functionalized nanoparticles
(NPs) are widely used in targeted
drug delivery and biomedical imaging due to their penetration into
living cells. The outer coating of most cells is a sugar-rich layer
of the cellular glycocalyx, presumably playing an important part in
any uptake processes. However, the exact role of the cellular glycocalyx
in NP uptake is still uncovered. Here, we in situ monitored the cellular
uptake of gold NPsfunctionalized with positively charged alkaline
thiol (TMA)into adhered cancer cells with or without preliminary
glycocalyx digestion. Proteoglycan (PG) components of the glycocalyx
were treated by the chondroitinase ABC enzyme. It acts on chondroitin
4-sulfate, chondroitin 6-sulfate, and dermatan sulfate and slowly
on hyaluronate. The uptake measurements of HeLa cells were performed
by applying a high-throughput label-free optical biosensor based on
resonant waveguide gratings. The positively charged gold NPs were
used with different sizes [d = 2.6, 4.2, and 7.0
nm, small (S), medium (M), and large(L), respectively]. Negatively
charged citrate-capped tannic acid (CTA, d = 5.5
nm) NPs were also used in control experiments. Real-time biosensor
data confirmed the cellular uptake of the functionalized NPs, which
was visually proved by transmission electron microscopy. It was found
that the enzymatic digestion facilitated the entry of the positively
charged S- and M-sized NPs, being more pronounced for the M-sized.
Other enzymes digesting different components of the glycocalyx were
also employed, and the results were compared. Glycosaminoglycan digesting
heparinase III treatment also increased, while glycoprotein and glycolipid
modifying neuraminidase decreased the NP uptake by HeLa cells. This
suggests that the sialic acid residues decrease, while heparan sulfate
increases the uptake of positively charged NPs. Our results raise
the hypothesis that cellular uptake of 2–4 nm positively charged
NPs is facilitated by glycoprotein and glycolipid components of the
glycocalyx but inhibited by PGs.